Papers by João A. Abrantes · AgingResearch.News

AAIC 2025 Abstract26 Dec
Latest results from the dose‐expansion part (Part 2) of the Brainshuttle™ AD study of trontinemab in people with Alzheimer’s disease
Trial in peopleInterventions
Paper
AAIC 2025 Abstract26 Dec
Interim biomarker results for trontinemab, a novel Brainshuttle™ antibody in development for the treatment of Alzheimer’s disease
Trial in peopleInterventions
Paper